ImaRx Therapeutics Reports Third Quarter Ended 2008 Financial Results

Published: Nov 13, 2008

TUCSON, Ariz., Nov. 13, 2008 (GLOBE NEWSWIRE) -- ImaRx Therapeutics, Inc. (OTCBB:IMRX), a biopharmaceutical company focused on the development of new treatments for vascular disorders leveraging its proprietary microbubble and ultrasound technology, today reported financial results for the quarter ended September 30, 2008.

Back to news